STAA241220P27500
- 3.10
- +2.10+210.00%
Staar Surgical Newsroom
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Analyst Ratings
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Cuts Target Price to $28
Express News | STAAR Surgical Co : Canaccord Genuity Cuts Target Price to $28 From $31
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Cuts Target Price to $23
STAAR Surgical's (NASDAQ:STAA) Earnings Have Declined Over Three Years, Contributing to Shareholders 71% Loss
STAAR Surgical to Participate in BTIG Ophthalmology Day
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $38
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $49
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $42
Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Cuts Target Price to $27
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA) and Stevanato Group (STVN)
STAAR Surgical Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Oppenheimer Maintains Staar Surgical(STAA.US) With Hold Rating
A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $31 to $49
Staar Surgical Price Target Cut to $31.00/Share From $41.00 by Canaccord Genuity
STAAR Surgical Company's (NASDAQ:STAA) P/E Still Appears To Be Reasonable